MASSDEVICE ON CALL — This year promises to be a big one for medical device legal battles, as bellwether trials for several high-profile device disputes are slated for later in 2013.
A pair of bellwether trials against Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics’ metal-on-metal hip implants are set take place in September and October, setting the framework for the ongoing litigation in New Jersey.
The lawsuits against DePuy allege that the company was aware of complications arising from its ASR metal-on-metal hip implants, but failed to warn physicians.
Bard already lost 1 lawsuit over the mesh products when a jury in July decided against the device maker, awarding patient and plaintiff Christine Scott $5 million for her injuries and her husband $500,000 for the damage to their love life.
The jury decision may bode ill for Bard and others in the midst of similar lawsuits against their mesh devices, including Johnson & Johnson (NYSE:JNJ), Endo Pharmaceuticals Holdings (NSDQ:ENDP) and Boston Scientific (NYSE:BSX).
FDA OKs clinical trial via crowd-sourcing
The FDA approved the 1st clinical trial to use crowd-sourcing and telemonitoring to assess outcomes, allowing researchers to virtually eliminate study visits.
Americans still over-screening for prostate cancer?
A study published in the Archives of Internal Medicine examined use of ambulatory healthcare services, finding decreases in unnecessary cervical screening and antibiotic use but an increase in unneeded prostate cancer screenings.
Real-world defibrillator patients match those in studies
Real-world outcomes of patients implanted with heart defibrillators match patients who received the same devices in carefully controlled clinical trials, researchers found.